Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report ; volume:8 ; number:1 ; day:14 ; month:9 ; year:2014 ; pages:1-5 ; date:12.2014
Journal of medical case reports ; 8, Heft 1 (14.9.2014), 1-5, 12.2014
- Creator
-
Kourouklaris, Andreas
- Contributor
-
Ioannou, Kyriakos
Athanasiou, Ioannis
Panagidou, Alexia
Demetriou, Kiproulla
Zavros, Michalis
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-8-307
- URN
-
urn:nbn:de:1111-201607114821
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kourouklaris, Andreas
- Ioannou, Kyriakos
- Athanasiou, Ioannis
- Panagidou, Alexia
- Demetriou, Kiproulla
- Zavros, Michalis
- SpringerLink (Online service)
Other Objects (12)
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Use of eculizumab in pregnancy-associated atypical hemolytic uremic syndrome
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Use of eculizumab in pregnancy-associated atypical hemolytic uremic syndrome
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Use of eculizumab in pregnancy-associated atypical hemolytic uremic syndrome
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report